🇺🇸 FDA
Patent

US 10894786

Substituted pyrazole derivatives as selective CDK12/13 inhibitors

granted A61PA61P35/00

Quick answer

US patent 10894786 (Substituted pyrazole derivatives as selective CDK12/13 inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P35/00